In the
context of a dispute relating to the termination of partnership contracts for
the development of some varieties of rapeseed, the Paris Court of Appeal
(International Commercial Chamber) on 18 May 2021, partially set aside an
arbitration award rendered on 23 November 2018 under the aegis of the
International Arbitration Chamber of Paris (CAIP), which ordered the company
Laboulet to pay nearly EUR 1.7 million to Phycomat and, among other things,
ordered Phycomat to compensate Laboulet for its loss of opportunity evaluated
around EUR 1 million.
The Paris
Court of Appeal dismissed Laboulet's action for partial annulment, but ruled in
favor of Phycomat by deeming admissible its second ground for annulment
according to which the tribunal did not comply with its mission by ruling ultra
petita, and its third ground for annulment according to which the tribunal did
not respect due process. The Court thus ruled that the award shall be partially
annulled and decided to reopen the proceedings with regards to Laboulet’s
compensation for loss of opportunity as it was not invoked before the arbitral
tribunal. 
Phycomat
was represented in the annulment proceedings by Caroline Duclercq, partner at
Medici.